Cardiac surgery Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.
Heart Surg Forum. 2020 Mar 24;23(2):E160-E164. doi: 10.1532/hsf.2829.
Acute aortic dissection is one of the most fatal conditions, with high surgical risks and severe postoperative complications. Treatment modalities vary from center to center, and a total arch replacement sometimes is not sufficient to provide a good result. Frozen elephant trunk (FET) offers a good option for a more complete repair. Because of its complexity and expense, however, this excellent technique is not always available. In this article, we present our hybrid technique including total arch replacement and retrograde thoracic endovascular aortic repair (TEVAR) for acute aortic dissection via a ministernotomy.
Our study aimed to estimate the safety, early results, and some midterm outcomes of total arch replacement in combination with retrograde TEVAR for acute aortic dissection from August 2013 to May 2017. We analyzed the intraoperative variables (duration of cross-clamp, circulatory arrest, ventilation, and intensive care unit stay), 30-day mortality, and early complications as well as the midterm results of these patients.
From August 2013 to May 2017, 22 patients (17 male) diagnosed with acute aortic dissection were treated with total arch replacement and concomitant retrograde endovascular repair via an upper ministernotomy. Mean age (± SD) was 60.8 ± 10.7 years. Thirty-day mortality was 4.5%: 1 patient died of acute renal failure. One patient had a postoperative stroke. The average number of stents used intraoperatively was 1.83. Midterm mortality was 1 patient (4.5%). Complete thrombosis of the false lumen in the thoracic aorta was achieved in 18 patients (90%).
Retrograde TEVAR in combination with total arch replacement via an upper ministernotomy might be safe and effective in treating acute type A aortic dissection, with fairly low mortality and perioperative complications, and a very good rate of total false lumen thrombosis in midterm follow up.
急性主动脉夹层是最致命的病症之一,手术风险高,术后并发症严重。治疗方式因中心而异,全主动脉弓置换有时不足以取得良好效果。冷冻象鼻技术(FET)为更完整的修复提供了一个很好的选择。然而,由于其复杂性和费用,这种优秀的技术并不总是可用。本文介绍了我们通过小开胸术实施的全主动脉弓置换联合逆行性胸主动脉腔内修复术(TEVAR)治疗急性主动脉夹层的杂交技术。
我们的研究旨在评估 2013 年 8 月至 2017 年 5 月期间通过小开胸术实施的全主动脉弓置换联合逆行性 TEVAR 治疗急性主动脉夹层的安全性、早期结果和部分中期结果。我们分析了术中变量(体外循环夹闭、停循环、通气和重症监护病房停留时间)、30 天死亡率和早期并发症以及这些患者的中期结果。
2013 年 8 月至 2017 年 5 月,22 例(男 17 例)急性主动脉夹层患者接受了全主动脉弓置换联合逆行性腔内修复术治疗,通过上小开胸术进行。平均年龄(±标准差)为 60.8 ± 10.7 岁。30 天死亡率为 4.5%:1 例患者死于急性肾功能衰竭。1 例患者术后发生中风。术中平均使用支架数量为 1.83 个。中期死亡率为 1 例(4.5%)。18 例患者(90%)胸主动脉假腔完全血栓形成。
通过上小开胸术实施逆行性 TEVAR 联合全主动脉弓置换术治疗急性 A 型主动脉夹层可能是安全有效的,具有较低的死亡率和围手术期并发症,中期随访中假腔完全血栓形成率非常高。